Texas Attorney General Ken Paxton sued Epic, alleging the company monopolizes the EHR market and restricts access to medical ...

An Eli Lilly drug candidate designed to hit three metabolic targets led patients to lose an average of 28.7% of their body weight in a late-stage clinical trial, setting a new high mark in the ...

Scholar Rock contends its experimental drug for spinal muscular atrophy can achieve what none of the currently available therapies can do to treat this rare disease. After positive data from a pivotal ...

Mark Cuban warned that many employers are collecting drug rebate money funded by their sick employees — a practice that can ...

Zocdoc, an online marketplace that helps patients find and book appointments with in-network providers, has partnered with healthcare ratings and patient reviews website Healthgrades, the companies ...

Empathy Health Technologies announced Wednesday that it raised $7.6 million to support its Sober Sidekick app, which helps prevent relapse by connecting those struggling with substance use disorder ...

A Pharvaris drug led to speedy relief and symptom resolution from the sudden swelling attacks caused by a rare genetic disorder, preliminary Phase 3 clinical trial results that pave the way for an FDA ...

The U.K. cost-effectiveness standard for drugs will increase by 25% in exchange for zero tariffs on the country’s ...

The statistics are startling. Healthcare professionals are five times more likely to encounter violence than any other occupation. Nearly half of nurses will encounter some form of physical violence ...

Americans largely trust their doctors but are skeptical of payers, drugmakers and hospital leadership — a divide fueled by ...

The CDC has caused outrage from many in the medical community after changing its webpage on Wednesday to include language that links vaccines to autism, despite numerous studies showing that there’s ...

Pfizer now has the required regulatory approval for its $4.9 billion acquisition of obesity drug developer Metsera, but whether and when that deal closes may hinge on the outcome of two lawsuits the ...